throbber
286
`
`VOLUME 2: FACJU7Y DESIGN, STERILIZATION AND PROCESSING
`
`The AF for minimum dose, which oftentimes is the dose measured at an interior location, is
`given by
`
`AF . _ D,er
`m,n - Dmin
`
`(4)
`
`In equation (4), D,ct is the dose measured at the reference location and Dm;n is the dose
`measured at the minimum dose location.
`It is important to note that when reference location dosimetry is used to monitor dose
`during routine processiJ1g of product, the minimum dose at an interior location is not measured
`rather it is calculated on the basis of a statistical relationship given by the AF. For this reason, it is
`standard practice to measure the dose distribution in more than one product load under the same
`processing conditions with three product loads considered the minimum number to be dose
`mapped. Statistical analysis of the data from three dose maps is used to evaluate reproducibility
`in the measured dose and uncertai11ty in the statistical relationship that is used to calculate the
`minimum dose. This estimate of statistical uncertainty in the calculated value of dose can be used
`to set process paramete.rs for routme irradiation of the product.
`
`Dose Mapping Electron Beam
`Because of the much shorter radiation mean-free path of high-energy electrons in materials
`than high-energy photons and the fact that we are dealing with a beam of electrons, shielding
`and scattering effects i11troduced by localized heterogeneities within a carton of product or
`even withm a unit of product in the carton can significantly affect the dose delivered to the
`product. For example, the range of 10 MeV electrons is approximately 5 cm in water and
`polymers that commonly serve as packaging materials and closure systems for pharmaceuticaJ
`products. ln a metal such as stainless steel, the range of 10 MeV electrons is less than 1 cm.
`Therefore, localized high-density regions can result in significant dose gradients within a small
`volume and shadowing of other regions in the carton of product. These factors need to be
`taken into account iJ1 the selection of the locations of dosimeters within the product load. There
`are no standard dose map grids as is sometimes the case for gamma or X-ray irradiation. Dose
`map grids in high-energy electron beam irradiation are unique to each product type. Jn
`electron beam irradiation, it is common practice to use reference location dosimetry for
`monitori11g dose during routine processing of product. An external surface such as the surface
`where the electron beam is illcident on the product load may sometimes serve as the reference
`location or it may be at a fixed location adjacent to the product load and simply referred to as the
`monitoring location. In the case where the reference location is on an externaJ surface, it
`sometimes may also represent the minimum dose zone, which would only require use of an AF
`to calculate the maximum dose delivered to the product load. To establish the reproducibility in
`dose delivered to tJ1e prodt1ct load and estimate the uncertainly i:n the AF(s) that is used to
`calculate dose, mttltiple product loads, that is, typically three, are dose mapped. The uncertainty
`in the dose measurement process should be taken iJ.1to account when setting process parameters.
`
`RADIATION CH EMISTRY
`Radiation Interactions with Parenteral Drug Products
`As we have seen, high-energy electrons injected into a drug product from a high-power
`accelerator or generated within the medium from Compton scattering of energetic photons are
`responsible for the changes ill the properties of the drtig product and its sterilization. These
`high-energy electrons, which typically have energies in the 1 to 10 MeV range, suddenly find
`themselves embedded in the surrounding medium. Atomic electrons of the atoms ill the
`medium effectively shield the attractive force of the positive charges of the nuclei, and the
`high-energy electrons experience only the repulsive Coulombic force that is instantly
`established between them. The velocity of a 1 MeV electron is of the order of magnitude
`1010 cm/sec, which is close to the speed of light. The velocity of atomic electrons is on the
`order of 100 times less. lt takes about 10- 17 seconds for a 1 MeV electron to cross a diameter of
`an atom. During that time an atomic electron remains practically stationary and "feels" the
`risi11g and falling action of the repulsive CouJombic force created by the approaching and
`
`Regeneron Exhibit 1016.301
`
`

`

`RADIATION STERILIZATION
`
`287
`
`leaving of the high-energy electron passing by. The momentum exchanged between the two
`electrons (the product of the electrostatic force and duration of the collision) is small in
`comparison with the kinetic energy of the incident electron but may be large in comparison
`with the binding energy of the orbital electron. If the exchanged energy exceeds the energy that
`binds the electron to an atom (ionization potential), ionization of that atom will occur, whereas
`the exchange of a smaller amount of energy will result in its excitation.
`Studies have shown that the energy exchange events in liquids and solids involve energy
`packets between 6 and 100 eY, the most probable being around 25 eV. This is true in simple
`molecules such as water and cyclohexane (19), as well as in macromolecules such as DNA (20).
`Obviously all materials consisting of low-Z elements, including biological materials aJ1d APis,
`absorb energy by similar mechanisms that occur with similar probabilities. The energy of 25 eV
`is sufficient for the creation of one or two ion pairs and one or two excited molecules in liquid
`water. The small element of volume within which energy deposition occurs and within which
`newly formed species are confined for a limited time is called a spur. Occasionally, a larger
`package of energy is absorbed forming a blob (100 500 eV) or a short sidetrack (500 eV 5 keV).
`Spurs outnumber blobs by about 50:1 and short tracks by abou.t 500:1. For cobalt-60 gamma
`rays and 1 MeV electrons in water, the partition of absorbed energy is approximately spurs:
`75%, blobs: 12%, and short tracks: 13% (21). Essentially the same distribution of probabilities
`exists in water vapor and ice underscoring the random character of primary interactions,
`irrespective of the phase. This leads to the estimate that the absorption of a J MeV electron
`creates about 25,000 spurs, 500 blobs, and 50 short tracks.
`The initial volume of a spur in water may be about 1 nm3 (22), and the volumes of blobs
`and short tracks may be orders of magnitude larger, 10 and 100 nm3
`, respectively. Together
`they may occupy the volume of the order 105 nm3 containing about 106 molecules of water.
`Sterilization dose of 25 kGy is equivalent to the absorption of J .56 x 10211 eV / g requiring total
`absorption of 1.56 x 1014 1-MeY electrons in 1 g of water. The absorption of this amount of
`energy would initially affect J .56 x 10w molecules/gout of 3.3 x 1022 molecules present in 1 g
`of water, or 1 in about 200. Allowing that more than 10 water molecules may be contained
`within a J nm3 spur reduces this estimate to less than one iJ1 2000.
`The above picture is oversimpUfied: there is a distribution of spur sizes and some
`overlapping of spms. Nevertheless, it teaches us that precursors of chemical change are
`initially inhomogeneously distributed only along the tracks of fast electrons while the rest of
`the volume remains unaffected. It also teaches us that a significant fraction of small molecules
`may initially escape ionization or excitation, but that larger molecules will not be spared of
`radiation acth1g directly. lt is also obvious that in solutions, it is mostly solvent molecules that
`absorb radiation energy resulting in the creation of reactive species. The initially inhomoge(cid:173)
`neous distribution of priJnary products: electrons, positive ions, and excited molecules
`thro1.1ghout the irradiated medittm is one of the key featttres of radiation chemistry.
`Spatial inhomogeneity determines the earliest stage of radiation action, which is termed
`physical stage. It starts at 10- 17 seconds with the absorptio11 of energy and extends to
`approximately 10- 13 seconds until thermal equmbrium has been reached. The probability of
`interactions of electronic systems of atoms with photons and electrons during that stage is
`perfectly random, and nothing can be done to reduce it or to decrease the amount of ionization
`and excitation. The energy required for the creation of one ion pair in gas 0/11) is similar (25 30 e V)
`for a wide range of compounds (23), which forms the basis for the expectation that approximately
`the same munber of ion pairs would initially be created, irrespective of the chemical nature of the
`substance. However, the amounts of radiation-induced changes that become measurable at later
`stages greatly differ depending on the medium.
`
`Radiation Chemical Yield
`In an empirical approach to quantify and compare chemical effects of irradiation, the
`measured amounts of radiation-induced chemical changes have been normalized to dose. The
`quantity obtained in this way is called radiation chemical yield (G):
`
`G(X) = C(X)
`pD
`
`(5)
`
`Regeneron Exhibit 1016.302
`
`

`

`288
`
`VOLUME 2: FACJL/7Y DESIGN, STERILIZATION AND PROCESSING
`
`where G(X) is the radiation chemical yield of substance X created, destroyed, or altered; C(X) is
`the concentration of substance X created, destroyed, or altered; p, the density; and 0, the dose.
`The unit of C(X) is mol/J but ru1 older unit (rnolecules/100 eV) is still sometimes used
`(1 mol/J = 9.65 x 106 molecules/100 eV). The knowledge of G values allows the fraction of
`molecules affected by irradiation of 1 kg of some substance to be estimated as:
`
`(6)
`
`C(X) = 10- 3 x G(X } x D x M
`C
`where C is molar concentration of the neat substance and Mis its molecular mass. The larger
`fraction of molecules will be affected by the Larger dose and the larger is the molecule. In
`water, G(X) accounting for all interactions could be on the order of 1 ~1mol/J, which, for the
`dose of 25 kGy, gives C(X)/C = 4.5 x 10-4, or about one out of 2000 molecules, which
`fortuitously well compares with the previous estimate.
`If there were no influence of the medium on the initially produced ion pairs, C(ions) .in
`all media would be 100/W, that is 3 4/100 eV (-0.3 0.4 pmol/J). However, measured values
`of radiation chemical yields of primary species electrons, ions, aod excited molecules strongly
`depend on the time of measurement and the nature of the medimn. This means that they are
`modified by the medimn during the intervening iJ1terval of temporal evolution called
`physicochemical stage that extends from 10- n to 10- 10 seconds.
`
`Liquid Formulations-Radiolysis of Water
`The understanding of physicochemical processes occurring at early stages of radiation act.ion
`helps in devising meaningful ways to mitigate radiation-induced damage to the parenteral
`drng product. Parenteral drugs in solid form or a dry state respond rather favorably to
`radiation. However, liquid formulations particularly those aqueous in nature present more
`challenges. The pecttliarities of aqueou.s radiation chemistry are discussed iJ1 this section.
`An important reaction occmring during physicochemical stage in liquid water is the
`fastest known chemical reaction:
`
`(7)
`
`which generates the strongest known oxidizing species, hydroxyl radical. It can oxidize any
`molecitle with which it comes in contact and is ma.inly responsible for the radiation-induced
`damage of solutes in irradiated aqueous solutions. Another route for the formation of hydroxyl
`radical is the dissociation of excited water molecules that becomes possible in the same time
`window with the onset of molecular vibrations:
`
`H20'-+ H" + "OH
`
`(8)
`
`On the same timescale, the reorientation of dipolar molecules leads to the solvation of charged
`species, notably the free electron becomes hydrated in water, which, as the strongest reducing
`species known, can affect radiation sterilization of aqueous solutions of reducible substances.
`During that time frame radiation-induced species react within spurs or escape from the
`spurs by diffusion into the bulk where homogeneous distribution of reactive species is
`eventually established. The recombination of radical species gives stable molecular products:
`
`"OH+ "OH -+ H202
`
`(9)
`
`(10)
`
`which, however, are of little concern for radiation sterilization of solutions.
`During the physicochemical stage, dielectric properties of the medium have the strongest
`modifying effect on radiation chemical yields of charged species. Dielectric constant of the
`medium detennmes the critical distance at which the Coulombic attractive force of the ion pair
`equals the thermal energy that drives them apart. Only those electrons that escape the
`recombmation with the parent ion become solvated a11d eventually participate in the bulk
`reactions. ln a polar liquid like water the probability that an electron wilJ escape the
`recombination with its parent ion steeply increases with the increase of the initial electron-ion
`
`Regeneron Exhibit 1016.303
`
`

`

`RADIATION STERILIZA710N
`
`289
`
`separation distance. Therefore, free ion yield is high in water and polar liquids and low in
`nonpolar liquids.
`At the beginning of the chemical stage radiation chemical yields (in ~1mol/J) are as
`follows: G(. OH) = 0.28, G(.H ) = 0.06 and G(eaq - ) = 0.27. Until this moment, the only
`modifying action on these yields was that of the medium itself, and no additives could have
`altered them. As it now comes to chemical reactions with the components of the medium, the
`complex interplay of ionization potentials, electron affinities, bond dissociation energies, and
`chemical reactivities of the involved species finally determine the outcome of the chemical
`stage on nanosecond to micro- and millisecond timescales.
`The extremely high rate constant of the reaction given by equation (7) and the high
`molarity of neat water even in concentrated solutions make the reactions given by equations (7)
`and (8) unavoidable. Any attempts to mitigate in advance ill effects of hydroxyl radical induced
`oxidations must admit the impossibility to prevent its formation and recognize that the first
`opportunity to convert it into a more innocuous species occurs only after it has been already
`formed.
`The hydroxyl radical can oxidize any molecule with which it comes in contact and is
`mainly responsible for radiation-induced damage of solutes in irradiated aqueous solutions. lf
`the substance of interest, an AP!, reacts with ·oH radical with the rate constant kAPJ giving an
`unwanted product P, it is possible to find a compound S with a preferably higher reactivity
`with ·oH (rate constant ks), which acts as a scavenger and which does not give P. The hydroxyl
`radical is thus given two channels to react:
`AP[+ •o H ~ P
`
`(11)
`
`s+ ·oH _, no P
`Radiation chemical yield of unwanted product P, G(P) is given by the ratio of _probabilities of
`·o H reacting in the channel giving P to the overall probability of ·oH reaction:
`G(P) = G(. OB)kAPi!AP11/(kAPifAPI] + kslSl)
`G(P) will be at minimum the higher the product k5[S], that is, the more reactive scavenger and
`the higher its concentration. The same formalism is applicable to all other reactive species.
`The hydrated electron and hydrogen atom may be considered a basic and an acidic form,
`respectively, of a reducing species in the radiol.ysis of water. Their interconve.rsi.on is possible
`because the respective chemical equilibria are strongly shifted to the right. In acidic media,
`hydrated electrons are converted into H· atoms:
`eaq - + H30+ - H· + H20
`whereas in basic media all H· become eaq- :
`H• +OH- _. e.q- + H20
`
`(12)
`
`(13)
`
`(14)
`
`(15)
`
`Using scavengers that specifically react only with the oxidizing or the reducing radicals, it is
`possible to achieve the presence of only one kind of radicals. In a reducing medium hydroxyl
`radicals are converted into H• atoms:
`
`(16)
`while in an aqueous solution satmated with N20 (0.02 mole/ L), eaq - are converted into ·ott:
`e.<J- + N20 + H20 ~ ·o H +OH- + N2
`(17)
`Tertiary butanol efficiently removes •oH and slowly reacts with H•, while other alcohols (e.g.,
`isopropanol) remove both tt• and ·oH. At the same time alcohols do not react with e,q_- ·
`
`Aqueous (Liquid and Frozen) Parenterals
`The absorption of radiation energy in a crystalline solid is 11ot focused on a single atom, but a
`collective excitation involving many electxons spread throughout the c1ystal lattice is induced.
`
`Regeneron Exhibit 1016.304
`
`

`

`290
`
`VOLUME 2: FACJLJ7Y DESIGN, STERILIZATION AND PROCESSING
`
`The energy that would have been localized on an individtrnl chemical bond in an isolated
`molecule in gas or in a molecule in solution is distributed over many bonds in a crystal.
`Consequently, radiation chemical yield of decomposition in a crystalline matrix is lower than
`in solution, which is in turn lower than that in gas, Ggas > Gliquid > Gsolid·
`The buildup of free radicals in solids at low doses proceeds proportionally to dose, then
`the rate of their accumulation decreases until the concentration reaches the limiting value. The
`limiting concentration is reached when sufficient free radicals are produced within each
`other's migration volume so that they can recombine. The upper value of the recombination
`radius critical for permanent trapping in a solid is considered to be about 1 nm (24).
`The uptake of radiation energy by a medium is essentially proportional to the total
`number of electrons (valence and bottnd) present in a unit volume, that is, proportional to the
`mass of material exposed to irradiation. On irradiation of solutions most energy is deposited in
`the solvent. In irradiated aqueous solutions, reactive species e. q- , H•, and · oH prodttced by
`radiolysis of water react with any dissolved substances that act as their scavengers and
`consequently sttffer chemical changes. Radiation-induced effects that occur as a consequence
`of the absorption of energy in the target compound are termed direct effects, whereas those
`that occur in the reactions between a target compound and reactive species produced in a
`solvent are termed indirect effects.
`
`Effect of Temperature
`Direct effects are not expected to depend on temperature. The effects of elevated temperature
`on chemical reactions of reactive species in solution that are responsible for the indirect effect
`can be described by the Arrhenius equation. As the activation energies are rather small
`(6 30 kJ/ moD, the effects on reaction rate constants are also not large. The effects of reduced
`temperature are more dramatic because a significant increase of solution viscosity impedes the
`diffusion of reactive species, which leads to their spending more time close to their respective
`places of origin and ultimately, to their enhanced recombination. For example, radiation
`chemical yield of e0q - is reduced by a factor of 10 on reducing the temperature from 5 to
`55°C (25) and that of the hydroxyl radical by a factor of 60 on reducing the temperature from
`20 to 40°C (26). The yields of products derived from electron or hydroxyl radical attack at
`these temperatures in ice would be reduced by about 90% and 99.7%, respectively, compared
`to fluid solutions. Because of the redticed mobility at low-temperature reactions, damaging to
`solute would be possible only at solute concentrations high enough to have solute molecules in
`a region of reactive species formation, which we have estimated to be one in 2000 water
`molecules. However, even at low temperature, larger molecules such as proteins cannot escape
`direct effects.
`
`Effect of Oxygen
`Oxygen normally does not react with stable compounds at room temperatme, but its
`paramagnetic properties make it reactive with free radicals, which are also paramagnetic
`species created by irradiation of AP[s, excipients, or solvents:
`R· +02 ....... Roo·
`The most simple rnute for creating free radicals directly is the dissociation of an excited
`molecule R-H yielding a hydrogen atom and a free radical residue R·:
`(R Hr --+ R° + H°
`(19)
`In an indirect radiation action, the abstraction of a hydrogen atom by H• or ·oH radicals
`formed in the radiolysis of water or dissociative electron attachment by a molecule R X,
`containfog a strongly electronegative substituent X, also yield free radicals:
`
`(18)
`
`R X + eaq - __. R° + x-
`
`(20)
`
`(21)
`
`Regeneron Exhibit 1016.305
`
`

`

`RADIATION STERILIZATION
`
`291
`
`Doubly allylic hydrogen atoms, such as found in polyunsaturated fatty acids, are
`particularly weakly bound to the backbone of a molecule, which makes these locations
`especially vulnerable to oxidation. Peroxyl-free radicals fonned by the reaction given by
`equation (18) propagate a chain reaction:
`Roo· + R H -' ROOH + R°
`which continue to produce damage of an oxidizable substance as long as there is a steady
`supply of oxygen.
`Oxidation is one of the major causes of dmg instability, even without radiation. The ill
`effects of oxidation can be avoided by the exclusion of oxygen that underscores the importance
`of packaging and closure systems. It can also be prevented by the use of compounds that
`interfere with the propagation of radical chains by competing with the reaction given by
`equation (22), which are known as antioxidants. An antioxidant molecule A H itself possesses
`a weakly bou11d hydrogen atom, the abstraction of whicl1 produces free radical A•, that is more
`stable (less reactive) than R· and that therefore cannot further propagate the chain reaction:
`Roo· + A H -+ ROOH + A.
`More detailed aspects of stabilization of pharmaceuticals to oxidative degradation can be
`found in (27).
`
`(22)
`
`(23)
`
`RADIATION EFFECTS
`When considering the effects of radiation on a parenteral dmg product, it is important to take
`into account all elements of the drug product that may be exposed to the radiation
`environment. This includes the container, closure systems, and packaging materials. If the
`drug product was previously sterilized using a modality other than radiation, some materials
`that were selected because of physical-chemical features or tribological attributes may not be
`radiation compatible, whicl1 would entail selection of different materials for the radiation
`sterilization process. Therefore, whenever possible it is important to select the modality of
`sterilization early in the development of a new drug product.
`
`Container/Closure Systems and Packaging
`Most materials that are found in container/ closure systems and packaging consist of different
`types of polymers and glass. ln the evaluation of the effects of radiation on these materials, it is
`important to take into account possible changes in mechanical properties, radiation-induced
`discoloration, and biocompatibility. Because glass is amorphous, its mechanical properties are
`tmchanged when exposed to radiation. However, most glass materials discolor in varying
`degrees when exposed to radiation, which may not be acceptable from the standpoint of
`aesthetics or possibly functional reasons. The degree of discoloration depends on the type and
`amount of impurities in the glass, which are a source for radiation-indttced stable conjugated
`chromophores. Some types of glass such as cerium oxide glass show less discoloration than
`borosilicate glass when exposed to radiation (8). A very high purity glass material such as
`synthetic fused silica also will not discolor when irradiated. Polymers fall into three general
`classes that include thermoplastics, thermosets, and elastomers. Thermoplastics are the class of
`polymers that are commonly selected for containment of a drug product, and closure systems
`are usually elastomeric in nature. A large compendium of information on the effects of
`radiation on these classes of polymers can be found in published references and irom the
`manufacturers of the polymers themselves (28,29). Only a few polymers are not radiation
`compatible and shottld not be used if radiation is the choice for sterilization. Polyacetals, for
`example, Delrin and Celcon, polytetrafluoroethylene, that is, Teflon, and natural polypropy(cid:173)
`lene are not radiation tolerant and should be avoided. Polypropylene auto-oxidizes and will
`continue to degrade following irradiation. A radiation~stabilized polypropylene with
`antioxidants may be used in some applications. Two elastomers that are not radiation tolerant
`and should be avoided are butyl rubber and a fluoroelastomer. For example, butyl rubber is
`friable and will shed particulates. It is important to note that a poor choice in the selection of
`the polymer is not the only reason a part may fail when it is exposed to radiation. Improper
`
`Regeneron Exhibit 1016.306
`
`

`

`292
`
`VOLUME 2: FACJL/7Y DESIGN, STERILIZATION AND PROCESSING
`
`processing of a polymer or incorrect design may lead to failure of a part that is .irradiated even
`though the polymer is considered radiation compatible. For example, thermoplastics are often
`fabricated using ru1 injection molding process. lf the conditions for fabrication are not
`optimum, for example, temperature during the mold process, the final part may contain
`residual tensile stresses. Irradiation leads to breakage of molecular bonds in the polymer.
`Because of the presence of residual tensile stresses, crazing and microcracking of the polymer
`may occur. In the design of a part, stress raisers should also be avoided, for example, avoid
`sharp corners in design of the part.
`
`Radiation Effects-Excipients, Biopolymers, and APls
`Excipients are used to promote pharmacological action of an APT by formulation of the drug
`product in a viable delivery system. Examples of excipients, some of which may appear in
`parenteral medications, include gum Arabic, talc, starch, and paraffin. The principal effects of
`radiation that need to be taken into account are change in color, change in pH, and lowering of
`viscosity. Past studies have shown that excipients should respond favorably up to doses
`required to sterilize the drug product, that is, 25 kGy or less (30). Loss of viscosity may be of
`some concern in some cases. lJ1 particular, some thickening agents may suffer a significant loss
`in viscosity at relatively low doses of radiation. Radiation-induced chain scissions in the
`aliphatic molecular structure of the cellulose component significantly lowers its molecular
`weight with a concomitant decrease in the viscosity of the thickening agent. Addition of a
`radical scavenger may significantly improve the radiation stability of the thickening agent.
`Biopolymers are used for controlled drug release (CDR) and controlled drug delivery
`(CDD) of APls following parentral administration (31). Biopolymers react to radiation in a
`manner similar to other polymers. There is a possibility of chain scissions, cross-linking, and
`formation of free radicals. The principal changes of concern from irradiation of biopolymers
`include change in color and physical properties, which may lead to a change in the drug
`release characteristics of the biopolymer. For example, polyester polymers such as poly(lactic
`acid) (PLA) and copolymer poly(lactic acid-co-glycolic acid) (PLGA) are routinely used in
`CDR/CDD applications. Radiation will reduce the molecular weight of these polymers, with
`the percentage reduction increasing with increase in absorbed dose. For drug products that
`have low levels of microbiological contamination, it is possible to set an acceptable minimum
`dose that satisfies the desired SAL while maintaining a maximum dose that keeps the
`reduction in molecular weight within acceptable limits.
`The principal effects of radiation on an APT are formation of small amounts of
`degradation by-products and possible changes in the chemical-physical properties of the API
`including pH, color, and viscosity. The radiation-induced degradation by-products may
`produce toxic extractables that need to be taken into account in the evaluation of the
`biocompatibility of the APL Changes in the chemical-physical properties of the APl cottld
`affect the efficacy of the drug product, that is, its potency. Because a vast variety of chemical
`entities may appear as the AP!s, it is almost impossible to accurately predict radiation
`sensitivity of individual compounds. Previous work on particular or related molecules may
`inform and guide the assessment of radiation stability of an API.
`The effects of irradiation on drugs have been attracting the attention of researchers over
`the past 60 years. Bibliometric count finds about 1400 references until the year 2000, peaking
`in the seventies. This literature has been periodically reviewed and a compilation of results
`from the selection of 217 papers on some 380 APl.s has recently been published in form of an
`encyclopedia (32). Most of the included drngs and excipients are used in sterile prodt1ct
`formulations suitable for parenteral administration. The material included in another more
`recent review (33) is partially overlapping with the former one giving, in addition, an insight
`into the more recent work, mainly originating from the authors' group. These data may
`provide clues to the parameters affecting the radiation stability of a drug, the types of possible
`radiolytic damage, and radiation chemical yields of stable radiolytic products under a variety
`of irradiation conditions. Together with radiation chemistry principles expounded in the
`previous section, these data can help the optimization of key parameters to reduce the
`radiolytic degradation of water-based parenteral dmg products. API's in a dry formulation, for
`
`Regeneron Exhibit 1016.307
`
`

`

`RADIATION STERILIZATION
`
`293
`
`example, powder or freeze dried, are being success.fully terminally sterilized on a commercial
`level using radiation. Parenteral medications in a liquid form present a greater challenge.
`
`IRRADIATION OF SPECIFIC DRUG PRODUCTS
`Vaccines
`The use of radiation to inactivate a pathogen in the preparation of a vaccine was explored at an
`early point in the evolution of the radiation sterilization industry (34). These early studies were
`typically conducted at relatively high doses of radiation, that is, >25 kGy, which was
`considered necessary to inactivate the pathogen. Even so, some successes were observed
`wherein sterility was achieved while the antigenic properties of the vaccine were preserved.
`Most of these studies appear to only have advanced to a preclinical stage. Over the past several
`years, there has been a renewed interest in the use of radiation in the preparation of vaccines.
`The reemergence of certain infectious diseases such as tuberculosis may have stimulated this
`renewed interest in vaccines that are prepared using irradiation. Dependent on the
`microorganism, the dose of radiation to inactivate the pathogen may be relatively low. For
`example, researchers at the University of California, San Diego, have shown that Listeria
`111011ocytoge11es, a bacterial pathogen, was inactivated at doses as low as 6 kGy and the
`irradiated vaccine still triggered long-term immunity in the vaccinated animals (35). However,
`viral pathogens, which typically have significantly higher D10 values than bacterial pathogens,
`may reqttire much higher doses of radiation, that is, greater than 25 kGy, to inactivate the
`pathogen. On the basis of studies that have been conducted over the past several years, a
`significant advantage of radiation in the preparation of vaccines may reside in the possible
`formulation of vaccines in a dry state, for example, freeze dried (36). A vaccine that is prepared
`in this manner could possibly be stored for long periods of time in an unrefrigerated state,
`shipped world wide to a location of need, ru1d reconstituted on site.
`
`Proteins
`Protein drugs are specific, exert their effects at low concentrations, and their virtually limitless
`number enables their use to influence a large variety of biological processes. Therapeutic
`proteins include monoclonal antibodies, growth factors, cytokines, soluble receptors,
`hormones, and proteins that block the hmction of a variety of infectious agents. Specific
`hmctions of proteins in the body strongly depend on their structu.res.
`Proteins are characterized by four levels of structural organization. Primary structure of
`proteins is defined by the amino acid sequence. The ability of antigenic structures to elicit
`immune response is mostly a sequence-dependent property. At this (primary) level of
`structu

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket